T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ)
Live price chart, market sentiment, and community perspectives for T-Rex 2X Inverse MSTR Daily Target ETF (CBOE: MSTZ).
Live price chart, market sentiment, and community perspectives for T-Rex 2X Inverse MSTR Daily Target ETF (CBOE: MSTZ).
On our desk, we are closely monitoring MSTZ's daily compounding mechanics. Because the fund seeks inverse investment results strictly for a single trading day, holding shares for any period longer than that means the return may have no resemblance to -200% of MSTR's performance over the same horizon. Risk management guidelines require strict intraday exits to avoid structural erosion.
Looking at the Q1 2026 filings for MSTZ, 16 hedge funds and large institutions hold about $7.67M in the ETF, with new positions outnumbering exits. However, overall capital invested has tightened, and we are seeing about 20% more put options compared to call options among institutional participants, indicating a cautious baseline stance toward leverage.
When evaluating potential client suitability for leveraged products like MSTZ listed on Cboe BZX, compliance officers must emphasize that the fund does not seek to achieve its stated inverse objective over multi-day periods. The 1.05% annualized expense ratio and wide price range—from a 52-week low of $3.09 to a high of $28.71—demand rigorous volatility-matching protocols before execution.
As a risk manager reviewing regulatory disclosures under the ETF Opportunities Trust, I note that MSTZ maintains a portfolio turnover rate of 0.00% despite holding derivatives to match its daily target. Trading desks must enforce strict suitability standards since inverse leveraged ETFs carry severe compounding risks for retail investors unaware of daily reset properties.
Market discussions on Stocktwits and Seeking Alpha highlight how closely MSTZ tracks MSTR's corporate treasury strategies, especially as valuation metrics like mNAV fluctuate around key thresholds. Sentiment shifts rapidly whenever Bitcoin exposure narratives face macro headwinds, driving sharp intraday spikes in the ETF's turnover.
Explore plasma cleansing, somatic organ swaps, and BCI.